Concepedia

Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials

Maria Octavia Rangel, Raysa Morales‐Demori, Sarah T. Voll, Marwan Wassouf, Rizcallah Dick, Rami Doukky

Journal of Nuclear Cardiology · 2014 · 13 citations · 12 references

DOI

Concepts

References

12

Prediction of Creatinine Clearance from Serum Creatinine

Donald W. Cockcroft, Henry Gault · ˜The œNephron journals/Nephron journals · 2008 · 15.4K citations

, , +15

Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial

Ami E. Iskandrian, Timothy M. Bateman, Luiz Belardinelli et al. · Journal of Nuclear Cardiology · 2007 · 345 citations

, , +17

Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging

Manuel D. Cerqueira, Patricia K. Nguyen, Peter Staehr et al. · JACC. Cardiovascular imaging · 2008 · 241 citations

, , +11

Novel Short-Acting A2A Adenosine Receptor Agonists for Coronary Vasodilation: Inverse Relationship between Affinity and Duration of Action of A2A Agonists

Zhenhai Gao, Zhihe Li, Stephen P. Baker et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 123 citations

, , +12

Comparative Profile of Vasodilation by CVT-3146, a Novel A2A Receptor Agonist, and Adenosine in Conscious Dogs

Gong Zhao, Axel Linke, Xiaobin Xu et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 60 citations

, , +16